BlueDot develops AI-driven infectious disease surveillance and early-warning solutions that combine human and artificial intelligence to track, contextualize, and anticipate disease risks. Its flagship product, BlueDot Insights, is a global infectious disease surveillance and early warning system. The company reports deployments of BlueDot Insights in several hospitals across North America, in 12 public health agencies worldwide, and within Air Canada. BlueDot positions its tools for governments, hospitals, and businesses to protect citizens, staff, patients, employees, and customers. The company intends to use new funding to develop its AI-driven product suite, grow sales and commercialization in government, healthcare, and insurance, and expand into new global markets. Led by Founder and CEO Dr. Kamran Khan, BlueDot is headquartered in Toronto, Canada. The company has raised capital to support commercialization and international expansion.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2019